TMPRSS2
Showing 1 - 25 of 124
COVID-19 Trial (Bicalutamide 150 Mg Oral Tablet, Placebo)
Withdrawn
- COVID-19
- Bicalutamide 150 Mg Oral Tablet
- Placebo
- (no location specified)
Jun 30, 2021
High Risk Prostate Cancer to Determine Prognosis
Active, not recruiting
- Prostate Cancer
-
Gatineau, Quebec, Canada
- +7 more
Sep 20, 2021
Angiotensin-converting Enzyme 2 Expression in Tonsils and
Withdrawn
- Adenoidectomy
- Tonsillectomy
- Storage of operating waste
-
Créteil, France
- +8 more
Jul 5, 2021
Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)
Recruiting
- Phlebotomy Dependent Polycythemia Vera
-
Orange, California
- +4 more
Aug 1, 2022
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg, Drug: Standard
Not yet recruiting
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg
- Drug: Standard treatment Standard treatment
- (no location specified)
Oct 23, 2020
COVID19 Trial in Padova (Nafamostat Mesilate, Placebo)
Recruiting
- COVID19
- Nafamostat Mesilate
- Placebo
-
Padova, ItalyAzienda Ospedale Università di Padova
Jun 4, 2021
Severe Acute Respiratory Syndrome Trial in Scottsdale, Tucson, Jacksonville (Camostat Mesilate, Standard of Care)
Recruiting
- Severe Acute Respiratory Syndrome
- Camostat Mesilate
- Standard of Care
-
Scottsdale, Arizona
- +2 more
Jan 7, 2021
Beta Thalassemia Intermedia Trial in Worldwide (IONIS TMPRSS6-LRx)
Active, not recruiting
- Beta Thalassemia Intermedia
-
Camperdown, New South Wales, Australia
- +18 more
Sep 23, 2022
Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate
Recruiting
- Prostate Cancer
-
Chicoutimi, Quebec, Canada
- +8 more
Oct 19, 2020
Impact of the Genetic Polymorphism on COVID-19 in Egypt
Recruiting
- COVID-19
-
Cairo, EgyptCairo University Hospitals
Jul 25, 2022
EDRN Prostate MRI Biomarker Study
Recruiting
- PSA
- Prostate Cancer
- MRI prostate
-
Ann Arbor, MichiganUniversity of Michigan
Jan 4, 2023
AERD - Aspirin Exacerbated Respiratory Disease Trial in Kraków (Aspirin 300 Mg Oral Tablet, Placebo)
Recruiting
- AERD - Aspirin Exacerbated Respiratory Disease
- Aspirin 300 Mg Oral Tablet
- Placebo
-
Kraków, PolandUniversity Hospital, Pulmunology Clinic
Apr 4, 2023
Hormone-refractory Prostate Cancer Trial in Spain (Enzalutamide)
Completed
- Hormone-refractory Prostate Cancer
-
Badalona, Barcelona, Spain
- +15 more
Sep 20, 2019
Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)
Completed
- Prostate Cancer
- Leuprolide acetate
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022
Conditions Influencing Health Status, Healthy, Prostate Cancer Trial in United States (laboratory biomarker analysis,
Active, not recruiting
- Conditions Influencing Health Status
- +2 more
- laboratory biomarker analysis
- transrectal prostate biopsy
-
Arcadia, California
- +4 more
Mar 17, 2022
Covid19, SARS-CoV Infection Trial in Brasilia (Proxalutamide, Standard of Care)
Withdrawn
- Covid19
- SARS-CoV Infection
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Feb 17, 2022
Prostate Cancer, Urine, Liquid Biopsy Trial in Edegem (Colli-Pee UAS devices)
Not yet recruiting
- Prostate Cancer
- +2 more
- Colli-Pee UAS devices
-
Edegem, Antwerpen, BelgiumUniversitair ziekenhuis Antwerpen
Jul 8, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Manaus (Proxalutamide, Placebo)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Proxalutamide
- Placebo
-
Manaus, Amazonas, BrazilSamel Hospital
Feb 17, 2022
Infertility, COVID, IVF Trial in Brussels (Blood sample)
Completed
- Infertility
- +2 more
- Blood sample
-
Brussels, BelgiumUz Brussels
Feb 16, 2022
Breast Cancer, Prostate Cancer, Urine Trial in Edegem (Colli-Pee UAS devices)
Recruiting
- Breast Cancer
- +3 more
- Colli-Pee UAS devices
-
Edegem, Antwerpen, BelgiumUniversitair ziekenhuis Antwerpen
Jul 6, 2022
Transplacental Transmission of COVID-19
Not yet recruiting
- SARS-COV-2 Infection
- Samples concern SARS-COV-2 + pregnant women at the time of childbirth
- Samples concern newborns of SARS-COV-2 + mothers at birth
-
Saint-Étienne, FranceChu Saint-Etienne
Nov 19, 2021
COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis
Not yet recruiting
- COVID19
- Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
- +4 more
-
Cairo, Kafr El-sheikh, Egypt
- +1 more
Jul 29, 2021
COVID-19, SARS-CoV2, Androgenetic Alopecia Trial in Brasilia (Proxalutamide, Standard of Care)
Completed
- COVID-19
- +5 more
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Dec 8, 2021
COVID-19 Trial (Drug: Isotretinoin plus Tamoxifen, Aerosolized Isotretinoin plus Tamoxifen)
Not yet recruiting
- COVID-19
- Drug: Isotretinoin plus Tamoxifen
- Aerosolized Isotretinoin plus Tamoxifen
- (no location specified)
Jul 10, 2021
In-vitro Diagnostic Test to Predict COVID-19 Mortality and
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
-
Madrid, SpainHospital Universitario Ramon y Cajal
Feb 17, 2022